(Date:2/9/2010)... endpoint Clinical ( www.endpointclinical.com ), a ... (IWR) systems, announced today that PULSE, a fully ... deploy clinical trial Integrated Response Technology (IRT) systems, ... clinical trials. This time and cost savings stems ... developers do not have to spend valuable time ...
(Date:2/9/2010)... A leading clinical research center in ... study an investigational drug designed as a possible treatment ... affects between 45 and 90 percent of women of ... not life threatening, dysmenorrhea can be debilitating and psychologically ... absenteeism from work and school. ,, Current therapies for ...
(Date:2/9/2010)... and AMSTERDAM , February 9 ... cancer diagnostics, announced today that,it has received the ... State ,Department of Health. The New York ... samples of MammaPrint, its FDA-cleared breast cancer recurrence,test. ... permit, Agendia has now obtained all major U.S. ...
(Date:2/9/2010)... Belgium , February 9 ... the Potential of Microplasmin to Improve the Treatment,of ... ,, ThromboGenics NV (Euronext ... and development of innovative treatments for eye,disease, vascular ... Phase II trial results, evaluating the product,s efficacy ...
Breaking Biology Technology:endpoint Saves Money and Time for Medical Research Teams Through PULSE 2endpoint Saves Money and Time for Medical Research Teams Through PULSE 3Peoria Clinical Research Center Tests Investigational Drug to Treat Painful Menstrual Cramps 2Agendia Receives New York State Laboratory Permit and Laboratory Accreditation by College of American Pathologists 2ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmology 2ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmology 3ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmology 4... Care managers can now quickly and easily access ... environment of care (EC) compliance with the ... interviews with EC experts called "EC Bits."EC Bits audio ... feature expert advice to help keep EC managers ...
... CITY, Calif., Feb. 24 Pearl Therapeutics announced,today that ... Oxford,Finance Corporation and Silicon Valley Bank, a member ... provided the capital which will be drawn in two,tranches. ... to be working with Oxford and SVB. They ...
... Feb. 24 Novasys Medical, Inc., a ... today that Noridian,Administrative Services, LLC, a regional ... now covering the non-surgical Renessa treatment,for women ... currently,administers benefits for approximately 4 million Medicare ...
Other Biology Technology:Web-based Audio Interviews Keep Environment of Care Managers Up-to-Date on Key EC Compliance Issues 2Pearl Therapeutics Secures $8 Million in Debt Financing 2Pearl Therapeutics Secures $8 Million in Debt Financing 3Noridian Medicare Now Covers Renessa(R) Treatment for Incontinence in Women 2... II xi 2-D system runs both gel dimensions in ... gels can be separated in a single run using ... core in much the same manner as the slab ... second-dimension slab gels may be cast in the casting ...
... Experion StdSens analysis kit for 25 chips ... perform standard-sensitivity RNA analysis (at nanogram levels) ... kit includes 25 RNA StdSens microfluidic chips, ... x 20 microliters RNA StdSens stain, 2 ...
... Rotator, variable speed, timer, SB3, Fully adjustable ... of tube holders to hold a number ... SB3 is ideal for aerating cultures, keeping ... mixing applications., The rotator can be used ...
...
Biology Products:Biology NavigationMedical Navigation